Epstein-Barr Virus: Inhibition of Replication by Three New Drugs-Reference-Cited by-同舟云学术

Epstein-Barr Virus: Inhibition of Replication by Three New Drugs

Published:1983-08-05 Issue:4610 Volume:221 Page:578-579
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Lin Jung-Chung¹,Smith M. Carolyn¹,Cheng Yung-Chi¹,Pagano Joseph S.²

Affiliation:

1. Cancer Research Center and Departments of Biochemistry and Nutrition, School of Medicine, University of North Carolina, Chapel Hill 27514

2. Cancer Research Center and Departments of Medicine and Microbiology and Immunology, University of North Carolina

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference18 articles.

1. CHENG, Y.C., ANTI-HERPES SIMPLEX VIRUS AND ANTI-HUMAN CELL-GROWTH ACTIVITY OF E-5-PROPENYL-2'-DEOXYURIDINE AND THE CONCEPT OF SELECTIVE PROTECTION IN ANTIVIRUS CHEMOTHERAPY, ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 18: 957 (1980).

2. CHENG, Y.C., DIFFERENTIAL ACTIVITY OF POTENTIAL ANTI-VIRAL NUCLEOSIDE ANALOGS ON HERPES-SIMPLEX VIRUS-INDUCED AND HUMAN CELLULAR THYMIDINE KINASES, ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 20: 420 (1981).

3. COLBY, B.M., EFFECT OF ACYCLOVIR [9-(2-HYDROXYETHOXYMETHYL)GUANINE] ON EPSTEIN-BARR VIRUS-DNA REPLICATION, JOURNAL OF VIROLOGY 34: 560 (1980).

4. DATTA, A.K., ACYCLOVIR INHIBITION OF EPSTEIN-BARR VIRUS-REPLICATION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES 77: 5163 (1980).

5. DECLERCQ, E, COMPARATIVE EFFICACY OF ANTIHERPES DRUGS AGAINST DIFFERENT STRAINS OF HERPES-SIMPLEX VIRUS, JOURNAL OF INFECTIOUS DISEASES 141: 563 (1980).

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi’s Sarcoma-Associated Herpesvirus Latent and Lytic Replications;mBio;2018-07-05

2. Repurposing cytarabine for treating primary effusion lymphoma by targeting KSHV latent and lytic replications;2018-04-11

3. Development of Practical Synthetic Method for 1-(2-Deoxy-2-Fluoro-4-Thio-β-D-Arabinofuranosyl) Thymine(S-FMAU) which is a Promising Therapeutic Agent for the Chronic Active Epstein Barr Virus Infection; CAEBV;Journal of Synthetic Organic Chemistry, Japan;2017

4. Epstein-Barr virus encephalitis after kidney transplantation and successful treatment with brivudine;Transplant International;2010-01-12

5. ANTIVIRAL AGENTS;Feigin and Cherry's Textbook of Pediatric Infectious Diseases;2009